{"id":"W2111155556","doi":"10.2337/dc13-2338","title":"Sodium-Glucose Cotransporter 2 Inhibition and Glycemic Control in Type 1 Diabetes: Results of an 8-Week Open-Label Proof-of-Concept Trial","year":2014,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":228,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada); Toronto General Hospital; University of Toronto","funders":"University Health Network","keywords":"Empagliflozin; Medicine; Glycemic; Internal medicine; Endocrinology; Type 2 diabetes; Diabetes mellitus; Insulin; Hypoglycemia; Dapagliflozin; Randomized controlled trial; Excretion","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002893359,0.0002324184,0.0007346583,0.0001839088,0.00002916713,0.00002595944,0.0001325859,0.000126507,0.00001714721],"category_scores_gemma":[0.00009978055,0.0002028345,0.00005457866,0.0002308723,0.0001432758,0.0002644842,0.00005278735,0.0001174478,0.00000431499],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004782521,"about_ca_system_score_gemma":0.00004972444,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002132958,"about_ca_topic_score_gemma":0.00003885776,"domain_scores_codex":[0.998331,0.0001005169,0.0005790934,0.0004064823,0.0002332321,0.000349664],"domain_scores_gemma":[0.9989487,0.0001120283,0.0002249245,0.0004040256,0.0001823201,0.0001279814],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1446225,0.01220029,0.2156003,0.00425036,0.001318006,0.00004446856,0.01103031,0.00008260008,0.05172797,0.0005621696,0.002197916,0.5563631],"study_design_scores_gemma":[0.6435663,0.04325767,0.02076788,0.001731582,0.001249294,2.816033e-7,0.001079616,0.002364654,0.2817578,0.0004555899,0.003085578,0.000683849],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952788,0.0008009275,0.00000560382,0.000145679,0.0001896084,0.002269777,0.0001750828,0.00002888184,0.001105673],"genre_scores_gemma":[0.9981361,0.00001587859,0.0002219731,0.0003528646,0.00008689561,0.000122915,0.0009782109,0.00003125778,0.00005389007],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5556793,"threshold_uncertainty_score":0.827135,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01921634408691658,"score_gpt":0.2617408166852331,"score_spread":0.2425244725983166,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}